MUSTANG BIO, INC. Cash Flow Statement
MBIO|4 years of annual SEC 10-K data (FY2016-FY2019)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
MUSTANG BIO, INC. used $19M in operating cash flow and negative free cash flow of $26M in FY2019.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|
| Net Income | -$30.7M | -$31.3M | -$4.5M | -$4.5M |
| Depreciation & Amortization | $630.0K | $2.0K | $0 | - |
| Operating Cash Flow | -$19.2M | -$12.9M | -$1.6M | -$1.6M |
| Capital Expenditures | $6.9M | $424.0K | - | - |
| Free Cash Flow | -$26.1M | -$13.4M | - | - |
| FCF Margin | - | -26744.0% | - | - |